Tailored-dose chemotherapy with gemcitabine and irinotecan in patients with platinum-refractory/resistant ovarian or primary peritoneal cancer: a phase II trial

OBJECTIVE: We investigated the efficacy and toxicity of tailored-dose chemotherapy with gemcitabine and irinotecan for platinum-refractory/resistant ovarian or primary peritoneal cancer. METHODS: We enrolled patients with ovarian or primary peritoneal cancer who received ≥2 previous chemotherapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Tate, Shinichi, Nishikimi, Kyoko, Matsuoka, Ayumu, Otsuka, Satoyo, Kato, Kazuyoshi, Takahashi, Yutaka, Shozu, Makio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767653/
https://www.ncbi.nlm.nih.gov/pubmed/33185049
http://dx.doi.org/10.3802/jgo.2021.32.e8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767653/
https://www.ncbi.nlm.nih.gov/pubmed/33185049
http://dx.doi.org/10.3802/jgo.2021.32.e8

Ejemplares similares